---

$12.88

-1.5500 ( -10.70% ) 208.4K

Immunic Inc is a clinical-stage biopharmaceutical company developing a pipeline of selective oral immunology therapies aimed at treating chronic inflammatory and autoimmune diseases, including ulcerative colitis, Crohn's disease, relapsing-remitting multiple sclerosis, and psoriasis. The company is developing small molecule products, which include IMU-838, which is a selective immune modulator that inhibits the intracellular metabolism of activated immune cells by blocking the enzyme DHODH; IMU-935 is an inverse agonist of RORyt, and IMU-856 targets the restoration of the intestinal barrier function.

Type: All Buy Sale Start date: End date: Filter Reset

Date	Type	Amount Purchased	Purchaser
2025-06-16	Buy	20000.00	Nash Duane
2025-06-09	Buy	12512.00	Tardio Jason
2025-06-06	Buy	15000.00	Vitt Daniel
2025-06-05	Buy	70000.00	Neermann Joerg
2025-06-04	Buy	25000.00	Whaley Glenn
2025-06-04	Buy	143075.00	Rudick Richard Alan
2024-11-13	Buy	87300.00	Rudick Richard Alan
2024-07-24	Sale	-100000.00	Skerjanec Simona
2024-07-12	Sale	-500000.00	Tardio Jason
2024-06-12	Sale	-100000.00	HOWSON TAMAR D